Hot Paths

Wave Life Sciences gains as JPMorgan suspends rating (update) (WVE:NASDAQ)

Duchenne muscular dystrophy genetic test

Hailshadow/iStock via Getty Images

Update 3:25pm: Adds company comment.

  • Wave Life Sciences (NASDAQ:WVE) rose 7.5% after JPMorgan suspended its rating, price target, and estimates on the company.
  • Some investors may be speculating that JPMorgan suspended its rating because it’s advising the company on some type
Exit mobile version